Filing Details
- Accession Number:
- 0001179110-12-012557
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-08 16:04:39
- Reporting Period:
- 2012-08-06
- Filing Date:
- 2012-08-08
- Accepted Time:
- 2012-08-08 16:04:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1232506 | G. Robert Savage | 8 Sylvan Way Parsippany NJ 07054 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-08-06 | 10,000 | $17.19 | 36,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-08-06 | 10,000 | $24.94 | 26,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (right to buy) | Disposition | 2012-08-06 | 10,000 | $0.00 | 10,000 | $17.19 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,000 | 2013-04-22 | No | 4 | M | Direct |
Footnotes
- The range of prices for the transactions reported on this line is between $24.87 and $24.97 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full informaton regarding the number of shares sold at each separate price.
- As of 8/6/2012, the original grant (20,000 shares granted on 4/22/2003) was fully vested. After the exercise of the options reported hereby, as of 8/06/2012, the remaining 10,000 shares covered by this option are vested but not exercised.